Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 739

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 6
Chunk 739
---
 reduced exercise price of $0.58
per share, and (ii) warrants to purchase an aggregate of up to 1,136,391
shares of Common Stock issued on August 5, 2024 (the “August Warrants”), at the reduced exercise price of $0.58
per share. The Company received aggregate gross proceeds of approximately $1.4
million, before deducting advisory fees and other expenses payable by it. In consideration of the immediate exercise of the October
Warrants and August Warrants by the holders thereof in accordance with the February Inducement Agreement, the Company issued unregistered
common warrants to purchase an aggregate of up to 2,926,166
shares of Common Stock (120%
of the number of shares of Common Stock issuable upon exercise of the October Warrants and August Warrants) to such
holders.

F-16